EC3 COST-MINIMIZATION ANALYSIS OF CAPECITABINE +...

Value in Health 2007 Vol. 10; Iss. 6

EC3 COST-MINIMIZATION ANALYSIS OF CAPECITABINE + OXALIPLATIN (XELOX) VS. INFUSIONAL 5-FU/LV + OXALIPLATIN (FOLFOX-6) AS FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER (MCRC) IN THE FRENCH SETTING

G Perrocheau, M Ducreux, M Hebbar, M Ychou, G Lledo, T Conroy, R Faroux, JY Douillard, A Pacull
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)64890-5
File:
PDF, 73 KB
english, 2007
Conversion to is in progress
Conversion to is failed